Literature DB >> 15109858

Morphology of sol-gel derived nano-coated coralline hydroxyapatite.

B Ben-Nissan1, A Milev, R Vago.   

Abstract

Current bone graft materials are mainly produced from coralline hydroxyapatite (HAp). Due to the nature of the conversion process, commercial coralline HAp has retained coral or CaCO(3,) and the structure possesses nanopores within the inter-pore trabeculae, resulting in high dissolution rates. Under certain conditions these features reduce durability and strength and are not utilised where high structural strength is required. To overcome these limitations, a new coral double-conversion technique has been developed. The technique involves a two-stage application route where, in the first stage, complete conversion of coral to pure HAp is achieved. In the second, a new sol-gel-derived HAp nano-coating is directly applied to cover the micro- and nano-pores within the intra-pore material, whilst maintaining the large pores. Biaxial strength was improved two-fold due to this unique double treatment. This application is expected to result in enhanced durability and longevity due to the monophasic hydroxyapatite structure and strength in the physiological environment. It is anticipated that this new material can be applied to load-bearing bone graft applications where high strength requirements are pertinent.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15109858     DOI: 10.1016/j.biomaterials.2004.02.006

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  13 in total

1.  Nano-structural bioactive gradient coating fabricated by computer controlled plasma-spraying technology.

Authors:  C Y Ning; Y J Wang; W W Lu; Q X Qiu; R W M Lam; X F Chen; K Y Chiu; J D Ye; G Wu; Z H Wu; S P Chow
Journal:  J Mater Sci Mater Med       Date:  2006-10       Impact factor: 3.896

2.  Fabrication, chemical composition change and phase evolution of biomorphic hydroxyapatite.

Authors:  Junmin Qian; Yahong Kang; Wei Zhang; Zhe Li
Journal:  J Mater Sci Mater Med       Date:  2008-06-11       Impact factor: 3.896

3.  Beyond the skeleton: Cnidarian biomaterials as bioactive extracellular microenvironments for tissue engineering.

Authors:  Razi Vago
Journal:  Organogenesis       Date:  2008-01       Impact factor: 2.500

Review 4.  Cnidarians biomineral in tissue engineering: a review.

Authors:  Razi Vago
Journal:  Mar Biotechnol (NY)       Date:  2008-05-15       Impact factor: 3.619

Review 5.  Calcium orthophosphates: occurrence, properties, biomineralization, pathological calcification and biomimetic applications.

Authors:  Sergey V Dorozhkin
Journal:  Biomatter       Date:  2011 Oct-Dec

6.  Mechanical properties of bovine hydroxyapatite (BHA) composites doped with SiO2, MgO, Al2O3, and ZrO2.

Authors:  Faik Nüzhet Oktar; Simeon Agathopoulos; L Sevgi Ozyegin; Oguzhan Gunduz; Nermin Demirkol; Yahya Bozkurt; Serdar Salman
Journal:  J Mater Sci Mater Med       Date:  2007-07-10       Impact factor: 3.896

7.  Specific biofunctional performances of the hydroxyapatite-sodium maleate copolymer hybrid coating nanostructures evaluated by in vitro studies.

Authors:  L E Sima; A Filimon; R M Piticescu; G C Chitanu; D M Suflet; M Miroiu; G Socol; I N Mihailescu; J Neamtu; G Negroiu
Journal:  J Mater Sci Mater Med       Date:  2009-06-20       Impact factor: 3.896

8.  Evaluation of biological properties of electron beam melted Ti6Al4V implant with biomimetic coating in vitro and in vivo.

Authors:  Xiang Li; Ya-Fei Feng; Cheng-Tao Wang; Guo-Chen Li; Wei Lei; Zhi-Yong Zhang; Lin Wang
Journal:  PLoS One       Date:  2012-12-18       Impact factor: 3.240

Review 9.  Evolving marine biomimetics for regenerative dentistry.

Authors:  David W Green; Wing-Fu Lai; Han-Sung Jung
Journal:  Mar Drugs       Date:  2014-05-13       Impact factor: 5.118

Review 10.  Marine Skeletons: Towards Hard Tissue Repair and Regeneration.

Authors:  Innocent J Macha; Besim Ben-Nissan
Journal:  Mar Drugs       Date:  2018-07-02       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.